A detailed history of Profit Investment Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Profit Investment Management, LLC holds 3,351 shares of AMGN stock, worth $886,305. This represents 0.84% of its overall portfolio holdings.

Number of Shares
3,351
Previous 3,450 2.87%
Holding current value
$886,305
Previous $1.08 Million 0.19%
% of portfolio
0.84%
Previous 0.67%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$309.38 - $337.38 $30,628 - $33,400
-99 Reduced 2.87%
3,351 $1.08 Million
Q2 2024

Jul 12, 2024

BUY
$262.75 - $319.31 $21,282 - $25,864
81 Added 2.4%
3,450 $1.08 Million
Q1 2024

Apr 11, 2024

SELL
$268.87 - $324.56 $7,797 - $9,412
-29 Reduced 0.85%
3,369 $957,000
Q3 2023

Oct 05, 2023

SELL
$218.65 - $271.46 $25,800 - $32,032
-118 Reduced 3.36%
3,398 $913,000
Q2 2023

Jul 10, 2023

SELL
$214.27 - $253.37 $8,785 - $10,388
-41 Reduced 1.15%
3,516 $780,000
Q1 2022

Apr 20, 2022

BUY
$219.27 - $242.57 $41,880 - $46,330
191 Added 5.67%
3,557 $859,000
Q4 2021

Jan 19, 2022

SELL
$198.88 - $227.6 $31,621 - $36,188
-159 Reduced 4.51%
3,366 $756,000
Q4 2020

Jan 20, 2021

SELL
$216.38 - $257.67 $1.2 Million - $1.43 Million
-5,546 Reduced 61.14%
3,525 $811,000
Q3 2020

Nov 09, 2020

BUY
$234.65 - $260.95 $10,089 - $11,220
43 Added 0.48%
9,071 $2.31 Million
Q2 2020

Jul 16, 2020

BUY
$197.81 - $242.74 $117,696 - $144,430
595 Added 7.06%
9,028 $2.13 Million
Q1 2020

Apr 23, 2020

BUY
$182.24 - $241.7 $513,734 - $681,352
2,819 Added 50.21%
8,433 $1.71 Million
Q1 2018

Apr 10, 2018

SELL
$169.43 - $198.0 $168,582 - $197,010
-995 Reduced 15.06%
5,614 $957,000
Q3 2017

Oct 18, 2017

BUY
$167.29 - $191.0 $1.11 Million - $1.26 Million
6,609
6,609 $1.23 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Profit Investment Management, LLC Portfolio

Follow Profit Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profit Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profit Investment Management, LLC with notifications on news.